GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS)

INR 2303.2

(-1.26%)

Eps Summary of GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited's latest annual eps in 2023 was 34.83 INR , down -3.38% from previous year.
GlaxoSmithKline Pharmaceuticals Limited's latest quarterly eps in 2024 Q2 was 14.91 INR , up 38.57% from previous quarter.
GlaxoSmithKline Pharmaceuticals Limited reported an annual eps of 36.05 INR in 2022, up 60.36% from previous year.
GlaxoSmithKline Pharmaceuticals Limited reported an annual eps of 22.48 INR in 2021, up 6.34% from previous year.
GlaxoSmithKline Pharmaceuticals Limited reported a quarterly eps of 14.91 INR for 2024 Q2, up 38.57% from previous quarter.
GlaxoSmithKline Pharmaceuticals Limited reported a quarterly eps of 2.70 INR for 2023 Q3, down -78.97% from previous quarter.

Annual Eps Chart of GlaxoSmithKline Pharmaceuticals Limited (2023 - 2004)

Historical Annual Eps of GlaxoSmithKline Pharmaceuticals Limited (2023 - 2004)

Year	Eps	Eps Growth
2023	34.83 INR	-3.38%
2022	36.05 INR	60.36%
2021	22.48 INR	6.34%
2020	21.14 INR	284.36%
2019	5.50 INR	-79.08%
2018	26.29 INR	27.0%
2017	20.70 INR	4.12%
2016	19.88 INR	-10.49%
2015	22.21 INR	-1.29%
2014	22.50 INR	-20.89%
2013	28.44 INR	-14.26%
2012	33.17 INR	31.11%
2011	25.30 INR	-23.54%
2010	33.09 INR	10.37%
2009	29.98 INR	-14.07%
2008	34.89 INR	7.95%
2007	32.32 INR	-0.65%
2006	32.53 INR	10.08%
2005	29.55 INR	52.79%
2004	19.34 INR	0.0%

Year	Eps	Eps Growth
2024 Q1	10.76 INR	-6.27%
2024 Q2	14.91 INR	38.57%
2023 Q3	2.70 INR	-78.97%
2023 FY	- INR	-3.38%
2023 Q4	11.48 INR	325.19%
2023 Q1	7.81 INR	-0.89%
2023 Q2	12.84 INR	64.4%
2022 FY	- INR	60.36%
2022 Q2	11.42 INR	62.22%
2022 Q1	7.04 INR	317.96%
2022 Q3	9.71 INR	-14.97%
2022 Q4	7.88 INR	-18.85%
2021 Q4	-3.23 INR	-139.53%
2021 Q1	7.15 INR	741.18%
2021 FY	- INR	6.34%
2021 Q2	12.06 INR	68.67%
2021 Q3	8.17 INR	-32.26%
2020 Q1	6.54 INR	-19.66%
2020 FY	- INR	284.36%
2020 Q4	0.85 INR	-90.8%
2020 Q3	9.24 INR	104.88%
2020 Q2	4.51 INR	-31.04%
2019 Q3	-39.03 INR	-231.5%
2019 FY	- INR	-79.08%
2019 Q4	8.14 INR	120.86%
2019 Q1	6.70 INR	-22.63%
2019 Q2	29.68 INR	342.99%
2018 Q2	5.95 INR	19.96%
2018 FY	- INR	27.0%
2018 Q4	8.66 INR	29.06%
2018 Q3	6.71 INR	12.77%
2018 Q1	4.96 INR	0.0%
2017 FY	- INR	4.12%
2017 Q1	1.56 INR	0.0%
2016 FY	- INR	-10.49%
2015 FY	- INR	-1.29%
2014 FY	- INR	-20.89%
2013 FY	- INR	-14.26%
2012 FY	- INR	31.11%
2011 FY	- INR	-23.54%
2010 FY	- INR	10.37%
2009 FY	- INR	-14.07%
2008 FY	- INR	7.95%
2007 FY	- INR	-0.65%
2006 FY	- INR	10.08%
2005 FY	- INR	52.79%
2004 FY	- INR	0.0%

Peer Eps Comparison of GlaxoSmithKline Pharmaceuticals Limited

Name	Eps	Eps Difference
Abbott India Limited	565.30 INR	93.839%
Cipla Limited	51.05 INR	31.773%
Gland Pharma Limited	46.90 INR	25.736%
Kopran Limited	10.57 INR	-229.518%
Marksans Pharma Limited	6.92 INR	-403.324%
NGL Fine-Chem Limited	66.88 INR	47.922%
Pfizer Limited	120.51 INR	71.098%
Sanofi India Limited	261.78 INR	86.695%
SMS Pharmaceuticals Limited	5.89 INR	-491.341%
TTK Healthcare Limited	44.47 INR	21.678%